PCK1 and myeloid sarcoma: Given current evidence suggesting that genetic susceptibility for MS and early events are largely related to immunologic dysfunction [21], we tested a model in which the effect of the PCK1 allele, which is associated with both smaller BPF and greater T2LV burden, might follow a causal pathway such that inflammation triggers neurodegeneration.